NCT06554197View on ClinicalTrials.gov

Evaluation of CMV/EBV-CMI in Haploid HSCT

RecruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

August 13, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2026

Conditions
Hematopoietic Stem Cell TransplantationCytomegalovirus InfectionsEpstein-Barr Virus Infections
Interventions
DIAGNOSTIC_TEST

CMV/EBV-CMI

The CMV/EBV-CMI is tested before conditioning regimen and 30 days, 45 days, 60 days, 90 days, 120 days, 180 days after transplantation.

Trial Locations (1)

215006

RECRUITING

First Affiliated Hospital of Soochow University, Suzhou

All Listed Sponsors
lead

The First Affiliated Hospital of Soochow University

OTHER